RELA and familial pancreatic carcinoma: Our results showed that NSD2 acted as a novel tumor suppressor in pancreatic cancer and revealed the multiple mechanisms by which NSD2 suppresses both p65 phosphorylation and downstream transcriptional activity during pancreatic tumorigenesis (Figure8).